Paul Hastings advised Merck on the deal. Merck, known as MSD outside the United States and Canada, announced a definitive agreement with Alydia Health, a commercial-stage medical...
Merck’s Acquisition of Alydia Health
XOMA and Viracta Therapeutics’ Multi-License Milestone and Royalty Monetization Transaction
Paul Hastings LLP advised Xoma Corporation on the deal. Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator announced its multi-license and milestone monetization transaction with Viracta Therapeutics....